ASSERTIO THERAPEUTICS, INC. Accounts Receivable
ASSERTIO THERAPEUTICS, INC. had Accounts Receivable of $12.95 million as of 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2020-05-11
- 2020-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $12.95M.
- 2019-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $42.74M.
- 2019-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $43.43M.
- 2019-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $34.31M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2020-03-31 | $12.95M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $42.74M 10-Q · filed 2020-05-11 | |
| 2019-09-30 | $43.43M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $34.31M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $43.49M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $37.21M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $43.91M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $42.15M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $62.43M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $72.48M 10-K · filed 2019-03-11 | $71.92M 10-K · filed 2018-03-01 |
| 2017-09-30 | $77.19M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $78.34M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $67.52M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $102.06M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $86.96M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $79.48M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $69.90M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $71.13M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $68.36M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $59.75M 10-Q · filed 2015-08-03 | |
| 2015-03-31 | $23.45M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $27.01M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $19.95M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $17.27M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $12.75M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $11.40M 10-K · filed 2016-02-26 | $11.45M 10-K · filed 2014-03-17 |
| 2013-09-30 | $8.31M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $6.72M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $5.29M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $3.60M 10-K · filed 2015-02-26 | $3.61M 10-K · filed 2013-02-22 |
| 2012-09-30 | $4.85M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $1.95M 10-Q/A · filed 2012-08-13 | |
| 2012-03-31 | $486.00K 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $4.40M 10-K · filed 2014-03-17 | $4.42M 10-K · filed 2012-03-08 |
| 2011-09-30 | $827.00K 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $7.36M 10-Q · filed 2011-08-02 | |
| 2010-12-31 | $6.09M 10-K · filed 2012-03-08 |